Table 2 Comparison of demographic and clinical characteristics and laboratory findings on ED arrival among NF patients with different concentrations of serum lactate
Admission blood lactate, mmol/l | 0.0–2.0 | 2.1–4.0 | 4.1–6.0 | 6.1–8.0 | > 8.0 | P value |
|---|---|---|---|---|---|---|
n | 145 | 275 | 141 | 84 | 62 | Â |
Age, years | 56.1 (30.1–68.9) | 57.1 (35.9–71.2) | 57.8 (33.8–75.1) | 59.3 (41.9–79.2) | 60.3 (42.3–85.6) | < 0.001 |
SBP at triage, mmHg | 137.4 (115.8–175.6) | 134.5 (115.4–189.7) | 130.8 (106.8–174.3) | 125.7 (105.2–170.9) | 124.8 (103.6–168.7) | 0.61 |
DBP at triage, mmHg | 87.6 (51.8–120.5) | 85.4 (52.4–117.9) | 82.7 (50.7–115.6) | 79.5 (42.7–114.2) | 76.9 (40.9–108.1) | 0.18 |
Episode of hypotension, n (%) | 12 (10.3) | 30 (10.9) | 23 (16.3) | 19 (22.6) | 21 (33.9) | < 0.001 |
SOFA score | 3 (0–6) | 4 (0–6) | 5 (1–7) | 7 (2–9) | 9 (4–16) | < 0.001 |
Hypothermia (BT < 36), n (%) | 15 (10.3) | 33 (12.0) | 18 (12.8) | 14 (13.1) | 8 (12.5) | 0.74 |
Hyperthermia (BT > =38), n (%) | 33 (22.8) | 70 (25.5) | 28 (19.9) | 17 (20.2) | 11 (17.7) | 0.56 |
Acidosis, n (%) | 10 (6.9) | 34 (12.4) | 26 (18.4) | 25 (29.8) | 21 (33.9) | < 0.001 |
Coagulopathy, n (%) | 16 (11.0) | 36 (13.1) | 22 (15.6) | 17 (20.2) | 15 (24.2) | < 0.001 |
Thrombocytopenia, n (%) | 13 (9.0) | 26 (9.5) | 11 (7.8) | 15 (17.9) | 11 (18.4) | 0.22 |
Anemia, n (%) | 18 (12.4) | 37 (13.5) | 19 (13.5) | 14 (16.7) | 11 (18.5) | 0.96 |
Episode of SpO2 < 90%, n (%) | 11 (7.6) | 25 (10.2) | 17 (12.1) | 11 (13.1) | 7 (11.9) | 0.77 |
In-hospital mortality, n (%) | 3 (2.1) | 6 (2.2) | 7 (5.0) | 11 (13.1) | 13 (21.0) | < 0.001 |
Serum albumin (g/dl) | 3.8 (2.6–4.1) | 3.7 (2.4–4.6) | 3.5 (2.1–3.9) | 3.1 (2.1–3.5) | 2.8 (1.8–3.4) | < 0.001 |
Serum creatinine (mg/dl) | 1.1 (0.4–2.8) | 1.3 (0.5–2.9) | 1.7 (0.9–3.8) | 2.1 (1.1–5.6) | 2.5 (1.4–7.9) | < 0.01 |
Serum glucose (mg/dl) | 128 (94–159) | 136 (93–166) | 158 (101–196) | 169 (105–201) | 184 (117–243) | < 0.01 |
Serum CRP (mg/dl) | 98 (15–124) | 112 (29–161) | 135 (35–184) | 169 (51–196) | 198 (81–230) | < 0.01 |
Diabetes mellitus, n (%) | 38 (26.2) | 61 (24.9) | 51 (36.1) | 31 (36.9) | 26 (42.3) | 0.06 |
Liver cirrhosis, n (%) | 24 (16.6) | 45 (18.5) | 32 (22.7) | 29 (34.5) | 24 (38.9) | 0.08 |
Chronic kidney disease, n (%) | 39 (26.9) | 69 (28.2) | 50 (35.5) | 33 (39.3) | 30 (48.7) | < 0.001 |